Thomas Eder

10PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)Statistical and quantitative geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12.

Selina Troester, Thomas Eder, Nadja Wukowits

|Aug 21, 2024
RNA sequestration in P-bodies sustains myeloid leukaemia.

Srikanth Kodali, Ludovica Proietti, Gemma Valcarcel

|May 28, 2024
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia.

Sophie Edtmayer, Agnieszka Witalisz-Siepracka, Bernhard Zdársky

|Oct 04, 2023
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.

Elizabeth Heyes, Anna S Wilhelmson, Anne Wenzel

|May 23, 2022
Comprehensive assessment of differential ChIP-seq tools guides optimal algorithm selection.

Thomas Eder, Florian Grebien

|Feb 24, 2021
Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.

Elizabeth Heyes, Luisa Schmidt, Gabriele Manhart

Pageof 2

Frequent Collaborators

10 joint publications

Florian Grebien

2 joint publications

Emilio Casanova

2 joint publications

Dagmar Stoiber

2 joint publications

Johannes Schmoellerl